[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370375-105":59,"doc-detail-370375-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","effect-of-metachronous-primary-and-secondary-solid-cancers-in-patients-with-multiple-myeloma-a-retrospective-study-from-a-single-center","Effect of metachronous primary and secondary solid cancers in patients with multiple myeloma - a retrospective study from a single-center","","Analysis of metachronous primary malignant solid tumors (MPMST) in multiple myeloma (MM) was conducted to clarify effects on survival risk and to compare MPMST arising before versus after MM. Retrospective clinical data for patients with MM and MPMST collected from 2015–2023 included sex, age, immunoglobulin isotype, ISS stage, and therapy, and outcomes were assessed using statistical comparisons and survival models. Older patients (≥65 years) showed higher risk of developing MPMST. Male patients, age ≥65, and ISS stage III had worse prognosis. The most common solid cancers before and after MM were lung, thyroid, and breast cancer, supporting more precise treatment planning.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/effect-of-metachronous-primary-and-secondary-solid-cancers-in-patients-with-multiple-myeloma-a-retrospective-study-from-a-single-center/370375/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/effect-of-metachronous-primary-and-secondary-solid-cancers-in-patients-with-multiple-myeloma-a-retrospective-study-from-a-single-center/370375.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of this retrospective study?","Question",{"text":112,"@type":113},"To analyze the effects of metachronous primary malignant solid tumors (MPMST) on multiple myeloma (MM) and to quantify the risk difference between MPMST occurring before versus after MM.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What patient factors were associated with a higher risk and worse prognosis?",{"text":117,"@type":113},"Older patients (≥65 years) had a higher risk of developing MPMST. Worse prognosis was observed in male patients, patients aged ≥65, and patients with ISS stage III.",{"name":119,"@type":110,"acceptedAnswer":120},"Which solid cancers were most common before and after MM?",{"text":121,"@type":113},"The top three solid cancers occurring before and after MM were lung, thyroid, and breast cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370375,1790488504,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","TYPE Original Research PUBLISHED 10 March 2025  \nDOI 10.3389/fimmu.2025.1516471  \nOPEN ACCESS  \nEDITED BY  \nAlessio Biagioni,  \nUniversity of Florence, Italy  \nREVIEWED BY  \nTan-Huy Chu,  \nTam Anh Research Institute, Vietnam Norbert Grzasko,  \nMedical University of Lublin, Poland  \n*CORRESPONDENCE  \nZhenyu Li  \n [lizhenyumd@163.com](lizhenyumd@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 24 October 2024  \nACCEPTED 19 February 2025  \nPUBLISHED 10 March 2025  \nCITATION  \nJi Y, Li H, Zhang H, Cheng H, Wang Y, Xu K and Li Z (2025) Effect of metachronous primary and secondary solid cancers inpatients with multiple myeloma: a retrospective study from a single-center. Front. Immunol. 16:1516471 .  \ndoi: 10.3389/fimmu.2025.1516471  \nCOPYRIGHT  \n© 2025 Ji, Li, Zhang, Cheng, Wang, Xu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nEffect of metachronous primary and secondary solid cancersin patients with multiple myeloma: a retrospective study from a single-center  \nYunfei Ji 1,2,3†, Hujun Li 1,2,3†, Huanxin Zhang 1,2,3, Hai Cheng 1,2,3, Ying Wang 1,2,3, Kailin Xu 1,2,3 and Zhenyu Li 1,2,3*  \n1 Department of Hematology, The Afﬁliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China, 2 Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China, 3 Key Laboratory of Bone Marrow Stem Cell, Xuzhou Medical University, Xuzhou, Jiangsu, China  \nStatement of translational relevance: Effects of metachronous primary malignant solid tumor (MPMST) on survival risk and prognosis of multiple myeloma (MM) and differences between MPMST occurring before and after MM remains unclear. Use of well-characterized clinical information of individual patient, we found that older patients with MM (≥ 65 years) had a higher risk of developing MPMST. Patients with MM and MPMST including male patients, aged ≥ 65 years and those with ISS stage III had a worse prognosis. The top three solid cancers occurred before and after MM were the lung, thyroid, and breast cancer. These ﬁndings provide detailed information for the precise treatment of patients with MM and MPMST.  \nObjective: To analyze the effects of MPMST on MM and the risk difference of MPMSTs occurring before and after MM.  \nMethods: Retrospective data from patients with MM and MPMST, including sex, age, immunoglobulin isotype, ISS stage, and therapy, were collected from 2015 to 2023 . Differences in variables, risk, and survival were compared using the c² test, logistic regression analysis and the Cox model, respectively.  \nResults: The 34 (1 . 57%) patients with MM and MPMST identiﬁed from a total of 2167 MM patients had a shorter overall survival. The survival risk was higher in male patients with MM and MPMST (HR: 3 . 96, 95% CI: 1 .05-14. 96), in those aged ≥ 65 years (HR: 3 .30, 95% CI: 1 .41-7.71), and with ISS stage III (HR: 4 . 08, 95% CI: 0.81-20. 65) . Patients with MM subsequent to CAR-T cell therapy had neither enhanced incidence rates of second solid cancers nor had longer overall survival time. Furthermore, the top three solid cancers occurred before or after MM were lung, thyroid, and breast cancer.  \nConclusion: Male patients, aged ≥ 65 years and MM patients with ISS stage III and MPMST had a worse prognosis.  \nKEYWORDS  \nmultiple myeloma, solid cancer, survival, risk, immunomodulator  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nIntroduction  \nGrowing evidence indicates that prolonged survival of inpatients with multiple myeloma (MM) patients can be attributed to the introduction of agents such as proteasome in","cbCaiq92wwL4ymQq","https://ap.wps.com/l/cbCaiq92wwL4ymQq","pdf",4539460,11,"English","# Introduction\n## Background on MM treatments and secondary cancers\n## Definition of metachronous vs synchronous tumors\n# Methods\n## Study design and patient data collection\n## Statistical analyses\n# Results\n## Patient characteristics and overall survival\n## Risk factors and cancer types before/after MM\n# Conclusion","[{\"question\":\"What is the main objective of this retrospective study?\",\"answer\":\"To analyze the effects of metachronous primary malignant solid tumors (MPMST) on multiple myeloma (MM) and to quantify the risk difference between MPMST occurring before versus after MM.\"},{\"question\":\"What patient factors were associated with a higher risk and worse prognosis?\",\"answer\":\"Older patients (≥65 years) had a higher risk of developing MPMST. Worse prognosis was observed in male patients, patients aged ≥65, and patients with ISS stage III.\"},{\"question\":\"Which solid cancers were most common before and after MM?\",\"answer\":\"The top three solid cancers occurring before and after MM were lung, thyroid, and breast cancer.\"}]","Effect of metachronous primary and secondary solid cancers in patients with multiple myeloma - a retrospective study from a single-center | PDF",1790188217,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea6d836376bd9a02ba3a1a2aef43e7a0.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f05e1808066ccfe5c4de7d913c9a9e1e.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2d7e0124be2e344128f4900679bdd5e.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de35206051f8c8e1ca6ee423a3e086d2.webp",980,1385]